Management and treatment of contact lens-related Pseudomonas keratitis

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 919-924

  Willcox, Mark DP ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Contact lens; Keratitis; Pseudomonas

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CEFAZOLIN; CEFTAZIDIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL KERATITIS; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG MONITORING; DRUG RESPONSE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PREVALENCE; PROSTHESIS INFECTION; PSEUDOMONAS; REVIEW; SOFT CONTACT LENS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84863456579     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S25168     Document Type: Review

References (56)

1. Jeng BH, Gritz DC, Kumar AB, etal. Epidemiology of ulcerative keratitis in northern California. Arch Ophthalmol. 2010;128:1022-1028.
2. Pachigolla G, Blomquist P, Cavanagh HD. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens. 2007;33:45-49.
3. Cariello AG, Passos RM, Yu MC, Hofling-Lima AL. Microbial keratitis at a referral center in Brazil. Int Ophthalmol. 2011;31:197-204.
4. Ibrahim YW, Boase DL, Creel IA. Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol. 2009;93:1319-1324.
5. Kaye S, Tuft S, Neal T, etal. Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51:362-368.
6. Orlans HO, Hornby SJ, Bowler IC. In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye. 2011;25:489-493.
7. Saeed A, D' Arcy F, Stack J, Collum LM, Power W, Beatty S. Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea. 2009;28:285-292.
8. van der Meulen IJ, van Rooij J, Nieuwendaal CP, Cleijnenbreugel HV, Geerards AJ, Remeijer L. Age-related risk factors, culture outcomes, and prognosis in patients admitted with infectious keratitis to two Dutch tertiary referral centers. Cornea. 2008;27:539-544.
9. Yilmaz S, Ozturk I, Maden A. Microbial keratitis in West Anatolia, Turkey: a retrospective review. Int Ophthalmol. 2007;27:261-268.
10. Cruciani F, Cuozzo G, Di Pillo S, Cavallaro M. Predisposing factors, clinical and microbiological aspects of bacterial keratitis: a clinical study. Clin Ter. 2009;160:207-210.
11. Kumar A, Pandya S, Kavathia G, Antala S, Madan M, Javdekar T. Microbial keratitis in Gujarat, Western India: findings from 200 cases. Pan Afr Med J. 2011;10:48-56.
12. Panda A, Satpathy G, Nayak N, Kumar S, Kumar A. Demographic pattern, predisposing factors and management of ulcerative keratitis: evaluation of one thousand unilateral cases at a tertiary care centre. Clin Experiment Ophthalmol. 2007;35:44-50.
13. Toshida H, Kogure N, Inoue N, Murakami A. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007;33;70-73.
14. Lavaju P, Arya SK, Khanal B, Amatya R, Patel S. Demographic pattern, clinical features and treatment outcome of patients with infective keratitis in the eastern region of Nepal. Nepal J Ophthalmol. 2009;1:101-106.
15. Norina TJ, Raihan S, Bakiah S, Ezanee M, Liza-Sharmini AT, Wan Hazzabah WH. Microbial keratitis: aetiological diagnosis and clinical features in patients admitted to Hospital Universiti Sains Malaysia. Singapore Med J. 2008;49:67-71.
16. Preechawat P, Ratananikom U, Lerdvitayasakul R, Kunavisarut S. Contact lens-related microbial keratitis. J Med Assoc Thai. 2007;90:737-743.
17. Sirikul T, Prabriputaloong T, Smathivat A, Chuck RS, Vongthongsri A. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea. 2008;27:283-287.
18. Uno T, Fukuda M, Ohashi Y, etal. Survey of severe contact lens-associated microbial keratitis in Japan. Nihon Ganka Gakkai Zasshi. 2011;115:107-115.
19. Rajpal K, Hall R, Long H, Wells A. Five-year experience of corneal scrapes at Wellington Eye Department, New Zealand. N Z Med J. 2007;120(1260):U2682.
20. Green M, Apel A, Stapleton F. A Longitudinal study of trends in keratitis in Australia. Cornea. 2008;27:33-39.
21. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea. 2008;27:22-27.
22. Keijser S, Kurreeman FA, de Keizer RJ, etal. IL-10 promotor haplotypes associated with susceptibility to and severity of bacterial corneal ulcers. Exp Eye Res. 2009;88:1124-1128.
23. Upadhyay MP, Karmacharya PC, Koirala S, etal. The Bhaktapur eye study: ocular trauma and antibiotic prophylaxis for the prevention of corneal ulceration in Nepal. Br J Ophthalmol. 2001;85:388-392.
24. Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in defined population from 1950 through 1988. Arch Ophthalmol. 1993;111:1665-1671.
25. Stapleton F, Keay L, Edwards K, Naduvilath T, Dart JK, Brian G, Holden BA. The incidence of contact lens-related microbial keratitis in Australia. Ophthalmol. 2008;115:1655-1662.
26. Liesegang TJ. Contact lens-related microbial keratitis: Part I: Epidemiology. Cornea. 1997;16:125-131.
27. Musa F, Tailor R, Gao A, Hutley E, Rauz S, Scott RA. Contact lens-related microbial keratitis in deployed British military personnel. Br J Ophthalmol. 2010;94:988-993.
28. Moriyama AS, Hofling-Lima AL. Contact lens-associated microbial keratitis. Arq Bras Oftalmol. 2008;71:32-36.
29. Amer Awan M, Reeks G, Rahman MQ, Butcher I, Ramaesh K. The patterns of in vitro antimicrobial susceptibility and resistance of bacterial keratitis isolates in Glasgow, United Kingdom. Clin Exp Optom. 2010;93:354-359.
30. Sueke H, Kaye S, Neal T, etal. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51:2519-2524.
31. Al-Shakarchi FI. Initial therapy for suppurative microbial keratitis in Iraq. Br J Ophthalmol. 2007;91:1583-1587.
32. Al-Yousuf N. Microbial keratitis in Kingdom of Bahrain: clinical and microbiology study. Middle East Afr J Ophthalmol. 2009;16:3-7.
33. Shah R, Shah M, Khandekar R, Al-Raisi A. Contact lens induced corneal ulcer management in a tertiary eye unit in Oman-a descriptive study. Sultan Qaboos Univ Med J. 2008;8:283-290.
34. Capriotti JA, Pelletier JS, Shah M, Caivano DM, Turay P, Ritterband DC. The etiology of infectious corneal ulceration in Sierra Leone. Int Ophthalmol. 2010;30:637-640.
35. Ubani UA. Bacteriology of external ocular infections in Aba, South Eastern Nigeria. Clin Exp Optom. 2009;92:482-489.
36. Bharathi MJ, Ramakrishnan R, Meenakshi R, Kumar CS, Padmavathy S, Mittal S. Ulcerative keratitis associated with contact lens wear. Indian J Ophthalmol. 2007;55:64-67.
37. Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol. 2010;58:497-507.
38. Inoue N, Toshida H, Mamada N, Kogure N, Murakami A. Contact lens-induced infectious keratitis in Japan. Eye Contact Lens. 2007;33:65-69.
39. Yu DK, Ng AS, Lau WW, Wong CC, Chan CW. Recent pattern of contact lens-related keratitis in Hong Kong. Eye Contact Lens. 2007;33:284-287.
40. Zhang C, Liang Y, Deng S, Wang Z, Li R, Sun X. Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004. Clinl Ophthalmol. 2008;2:575-579.
41. Fong CF, Hu FR, Tseng CH, Wang IJ, Chen WL, Hou YC. Antibiotic susceptibility of bacterial isolates from bacterial keratitis cases in a university hospital in Taiwan. Am J Ophthalmol. 2007;144:682-689.
42. Pandita A, Murphy C. Microbial keratitis in Waikato, New Zealand. Clin Exp Ophthalmol. 2011;39:393-397.
43. Edwards K, Keay L, Naduvilath T, Snibson G, Taylor H, Stapleton F. Characteristics of and risk factors for contact lens-related microbial keratitis in a tertiary referral hospital. Eye. 2009;23:153-160.
44. Stapleton F, Keay LJ, Sanfilippo PG, Katiyar S, Edwards KP, Naduvilath T. Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia. Am J Ophthalmol. 2007;144:690-698.
45. Hall RC, McKellar MJ. Bacterial keratitis in Christchurch, New Zealand, 1997-2001. Clin Exp Ophthalmol. 2004;32:478-481.
46. Sy A, Srinivasan M, Mascarenhas J, et al. Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Invest Ophthalmol Vis Sci. 2012;53:267-272.
47. Mohammadpour M, Mohajernezhadfard Z, Khodabande A, Vahedi P. Antibiotic susceptibility patterns of Pseudomonas corneal ulcers in contact lens wearers. Middle East Afr J Ophthalmol. 2011;18:228-231.
48. McAllum PJ, McGhee CNJ. Prescribing trends in infectious keratitis: a survey of New Zealand ophthalmologists. Clin Experiment Ophthalmol. 2003;31:496-504.
49. Keay L, Edwards K, Naduvilath T, etal. Microbial keratitis: predisposing factors and morbidity. Ophthalmology. 2006;113:109-111.
50. O'Brien TP, Maguire MG, Fink NE, Alfonso E, McDonnell P; The Bacterial Keratitis Study Research Group. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Arch Ophthalmol. 1995;113:1257-1265.
51. Khokhar S, Sindhu N, Mirdha BR. Comparison of topical 0.3% ofloxacin to fortified tobramycin-cefazolin in the therapy of bacterial keratitis. Infection. 2000;28:149-152.
52. Chew FL, Soong TK, Shin HC, Samsudin A, Visvaraja S. Topical piperacillin/tazobactam for recalcitrant pseudomonas aeruginosa keratitis. J Ocular Pharmacol Ther. 2010;26:219-222.
53. McCormick C, Caballero A, Tang A, Balzli C, Song J, O'Callaghan R. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis. Curr Med Res Opin. 2008;24:1569-1575.
54. Oliveira AD, d'Azevedo PA, Francisco W. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil. Cornea. 2007;26:194-198.
55. Ku JY, Kim P, Tong J, Wechsler A, McCluskey P. Multiresistant Pseudomonas keratitis. Clin Exp Ophthalmol. 2010;38:818-819.
56. Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51:4151-4155.